UBE2D1 and hepatocellular carcinoma: In both SNU-739 and HCC-LM3 cells, the knockdown of UBE2D1 resulted in a notable enhancement in the susceptibility of the cells to chemotherapeutic agents, as evidenced by reduced rates of cell proliferation and colony formation (Fig. 3B–E).